Biosensor Technology
Proprietary pocket-sized technology, bringing laboratory testing to the point-of-care to improve patient outcomes
Single point testing & continuous monitoring
Quantitative results
AI-based point-of-care diagnostics
Low-cost platform technology
Technology
Using ZiO Health's proprietary biosensor technology & machine learning algorithms we combine real-time results with the patients unique profile to enhance patient care
Therapeutic Drug Monitoring - Vancomycin
We test free & total vancomycin levels
The 'free vancomycin' level is currently estimated based on 'total vancomcyin' test results, leading to further inaccurate dosing
Significant cost reduction in the process
The process used today involves numerous inputs from various experts. The Vancomycin trough test alone costs over $100 per test
Dose individualisation to enhance drug efficacy & reduce adverse side effects
Current dosing models generalise everyone's health profile based on the population rather than considering individual's differing profiles
Reduced length of hospital stay
In the US, 60% of vancomycin doses are administered outside the therapeutic range leading to adverse side effects & ineffective treatment
Partnerships
Partnerships
We are interested in partnerships for:
-
R&D & technology discovery
-
Development of point-of-care devices for customized applications
All our partnerships provide access to ZiO Health’s biosensor platform
The Benefits Are Endless
Supported by
.png)
.png)
.png){kind=logo}
.png)
.png)
